: The AMEDEO Literature Guide

Home

Fast Track

My Amedeo

FAQ

About

Flying Publisher

	Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

Hepatitis

Free Subscription

Articles published in Hepatology
Retrieve available abstracts of 358 articles:
HTML format
Text format

Single Articles

February 2012

SCULL MA , Ploss A
Exiting from uncharted territory: Hepatitis C virus assembles in mouse cell lines.
Hepatology. 2012;55:645-8.
PubMed Text format Related articles

January 2012

SCHOLTES C , Ramiere C, Rainteau D, Perrin-Cocon L, et al
High plasma level of nucleocapsid-free envelope glycoprotein-positive lipoproteins in hepatitis C patients.
Hepatology. 2012 Jan 30. doi: 10.1002/hep.25628.
PubMed Text format Related articles Abstract available

MERCHANTE N , Rivero-Juarez A, Tellez F, Merino D, et al
Liver stiffness predicts clinical outcome in HIV/HCV-coinfected patients with compensated liver cirrhosis.
Hepatology. 2012 Jan 25. doi: 10.1002/hep.25616.
PubMed Text format Related articles Abstract available

SANCHO-BRU P , Altamirano J, Rodrigo-Torres D, Coll M, et al
Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis.
Hepatology. 2012 Jan 25. doi: 10.1002/hep.25614.
PubMed Text format Related articles Abstract available

RASMUSSEN AL , Tchitchek N, Susnow NJ, Krasnoselsky AL, et al
Early transcriptional programming links progression to hepatitis C virus-induced severe liver disease in transplant patients.
Hepatology. 2012 Jan 25. doi: 10.1002/hep.25612.
PubMed Text format Related articles Abstract available

POLLICINO T , Amaddeo G, Restuccia A, Raffa G, et al
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels.
Hepatology. 2012 Jan 23. doi: 10.1002/hep.25592.
PubMed Text format Related articles Abstract available

LI N , Zhang L, Chen L, Feng W, et al
MxA inhibits hepatitis B virus replication by interaction with core protein HBcAg.
Hepatology. 2012 Jan 23. doi: 10.1002/hep.25608.
PubMed Text format Related articles Abstract available

D'AMBROSIO R , Aghemo A, Grazia Rumi M, Ronchi G, et al
A morphometric and immunohistochemical study to assess the benefit of an svr in hcv cirrhotic patients.
Hepatology. 2012 Jan 23. doi: 10.1002/hep.25606.
PubMed Text format Related articles Abstract available

HOPPE-SEYLER K , Sauer P, Lohrey C, Hoppe-Seyler F, et al
The inhibitors of nucleotide biosynthesis leflunomide, FK778, and mycophenolic acid activate hepatitis b virus replication In Vitro.
Hepatology. 2012 Jan 23. doi: 10.1002/hep.25602.
PubMed Text format Related articles Abstract available

REMBECK K , Westin J, Lindh M, Hellstrand K, et al
Association between IL28B-related genetic variants and liver histopathology differs between hcv genotypes.
Hepatology. 2012 Jan 23. doi: 10.1002/hep.25598.
PubMed Text format Related articles

FISCHER J , Bohm S, Scholz M, Muller T, et al
Combined effects of different IL28B gene variants on the outcome of dual combination therapy in chronic HCV type 1 infection.
Hepatology. 2012 Jan 11. doi: 10.1002/hep.25582.
PubMed Text format Related articles Abstract available

SUN JH , O' Boyle Ii DR, Zhang Y, Wang C, et al
Impact of a baseline polymorphism on the emergence of resistance to the HCV NS5A replication complex inhibitor BMS-790052.
Hepatology. 2012 Jan 11. doi: 10.1002/hep.25581.
PubMed Text format Related articles Abstract available

KAMAR N , Legrand-Abravanel F, Dalton HR, Izopet J, et al
Hepatitis E virus-specific T-cell response after transplantation.
Hepatology. 2012 Jan 11. doi: 10.1002/hep.25578.
PubMed Text format Related articles

LIU L , Fisher BE, Thomas DL, Cox AL, et al
Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution.
Hepatology. 2012 Jan 11. doi: 10.1002/hep.25575.
PubMed Text format Related articles Abstract available

December 2011

PAN Q , de Ruiter PE, Metselaar HJ, Kwekkeboom J, et al
Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C virus infection in vitro and in vivo.
Hepatology. 2011 Dec 27. doi: 10.1002/hep.25562.
PubMed Text format Related articles Abstract available

DENNISTON MM , Monina KR, McQuillan GM, Jiles RB, et al
Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: NHANES 2001-08.
Hepatology. 2011 Dec 27. doi: 10.1002/hep.25556.
PubMed Text format Related articles Abstract available

ROWE I , Armstrong M, Houlihan D
Prioritising treatment experienced patients with hepatitis C infection for treatment with telaprevir: A number needed to treat approach.
Hepatology. 2011 Dec 27. doi: 10.1002/hep.25553.
PubMed Text format Related articles

PEARLMAN BL , Ehleben C
Impact of IL28B on treatment outcome in hepatitis C virus G1/4 patients receiving response-guided therapy with peginterferon alpha-2a/ribavirin.
Hepatology. 2011 Dec 27. doi: 10.1002/hep.25552.
PubMed Text format Related articles

SINGAL AK , Bashar H, Anand BS, Jampana SC, et al
Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: Exploratory analysis from UNOS database.
Hepatology. 2011 Dec 24. doi: 10.1002/hep.25544.
PubMed Text format Related articles Abstract available

VOLAREVIC V , Milovanovic M, Ljujic B, Pejnovic N, et al
Galectin-3 deficiency prevents concanavalin A- induced hepatitis in mice.
Hepatology. 2011 Dec 24. doi: 10.1002/hep.25542.
PubMed Text format Related articles Abstract available

REDDY SK , Steel JL, Chen HW, Demateo DJ, et al
Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease.
Hepatology. 2011 Dec 20. doi: 10.1002/hep.25536.
PubMed Text format Related articles Abstract available

KHACHATOORIAN R , Arumugaswami V, Ruchala P, Raychaudhuri S, et al
A cell-permeable hairpin peptide inhibits hepatitis C viral nonstructural protein 5A mediated translation and virus production.
Hepatology. 2011 Dec 20. doi: 10.1002/hep.25533.
PubMed Text format Related articles Abstract available

DONG C , Mohammad Z, Mixson-Hayden T, Dai X, et al
Suppression of alpha interferon signaling by hepatitis E virus.
Hepatology. 2011 Dec 20. doi: 10.1002/hep.25530.
PubMed Text format Related articles Abstract available

DIETERICH D
The end of the beginning for hepatitis C treatment.
Hepatology. 2011 Dec 16. doi: 10.1002/hep.25528.
PubMed Text format Related articles

WU T , Zhu FC, Huang SJ, Zhang XF, et al
Safety of the hepatitis E vaccine for pregnant women: A preliminary analysis.
Hepatology. 2011 Dec 13. doi: 10.1002/hep.25522.
PubMed Text format Related articles

SEBASTIANI G , Alberti A
Diagnostic algorithms for liver fibrosis in hepatitis C: Are they ready to avoid liver biopsy?
Hepatology. 2011 Dec 12. doi: 10.1002/hep.25517.
PubMed Text format Related articles

COBB B , Vilchez RA
An update on treatment of HCV genotype 1 infection and viral load assessments.
Hepatology. 2011 Dec 12. doi: 10.1002/hep.25516.
PubMed Text format Related articles

GHANY MG , Nelson DR, Strader DB, Thomas DL, et al
Re: HEP-11-1628 - An update on treatment of genotype 1 chronic hepatitis c virus infection: 2011 practice guidelines by the american association for the study of liver diseases.
Hepatology. 2011 Dec 12. doi: 10.1002/hep.25524.
PubMed Text format Related articles

QUARATO G , D'Aprile A, Gavillet B, Vuagniaux G, et al
The cyclophilin inhibitor alisporivir prevents hepatitis C virus- mediated mitochondrial dysfunction.
Hepatology. 2011 Dec 2. doi: 10.1002/hep.25514.
PubMed Text format Related articles Abstract available

ZHANG L , Yesupriya A, Hu DJ, Chang MH, et al
Variants in ABCB1, TGFB1, and XRCC1 genes and susceptibility to viral hepatitis A infection in mexican americans.
Hepatology. 2011 Dec 2. doi: 10.1002/hep.25513.
PubMed Text format Related articles Abstract available

MCGARRY LJ , Pawar VS, Parekh HH, Rubin JL, et al
Economic model of a birth cohort screening program for hepatitis C virus.
Hepatology. 2011 Dec 2. doi: 10.1002/hep.25510.
PubMed Text format Related articles Abstract available

PETTA S , Torres D, Fazio G, Camma C, et al
Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations.
Hepatology. 2011 Dec 2. doi: 10.1002/hep.25508.
PubMed Text format Related articles Abstract available

ANDRUS L , Marukian S, Jones CT, Catanese MT, et al
Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells.
Hepatology. 2011;54:1901-12.
PubMed Text format Related articles Abstract available

GREBELY J , Dore GJ
An expanding role for primary care providers in the treatment of hepatitis C virus infection in the community.
Hepatology. 2011;54:2259-61.
PubMed Text format Related articles

November 2011

REIN DB , Stevens G, Theaker J, Wittenborn JS, et al
The global burden of hepatitis E virus.
Hepatology. 2011 Nov 26. doi: 10.1002/hep.25505.
PubMed Text format Related articles Abstract available

ALBECKA A , Belouzard S, de Beeck AO, Descamps V, et al
Role of LDL receptor in the hepatitis c virus life cycle.
Hepatology. 2011 Nov 26. doi: 10.1002/hep.25501.
PubMed Text format Related articles Abstract available

HARTRIDGE-LAMBERT SK , Stein EM, Markowitz AJ, Portlock CS, et al
Hepatitis C and non-Hodgkin lymphoma: The clinical perspective.
Hepatology. 2011 Nov 26. doi: 10.1002/hep.25499.
PubMed Text format Related articles Abstract available

KOWDLEY KV , Wang CC, Welch S, Roberts H, et al
Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin.
Hepatology. 2011 Nov 22. doi: 10.1002/hep.24804.
PubMed Text format Related articles Abstract available

CALLAND N , Albecka A, Belouzard S, Wychowski C, et al
(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
Hepatology. 2011 Nov 22. doi: 10.1002/hep.24803.
PubMed Text format Related articles Abstract available

HU L , Zhai X, Liu J, Chu M, et al
Genetic variants in HLA-DP/DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development.
Hepatology. 2011 Nov 22. doi: 10.1002/hep.24799.
PubMed Text format Related articles Abstract available

WARD JW , Lok AS, Thomas DL, El-Serag HB, et al
Report on a single topic conference on "chronic viral hepatitis - strategies to improve effectiveness of screening and treatment"
Hepatology. 2011 Nov 22. doi: 10.1002/hep.24797.
PubMed Text format Related articles Abstract available

WANG S , Qiu L, Yan X, Jin W, et al
Loss of MiR-122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G1 modulated P53 activity.
Hepatology. 2011 Nov 22. doi: 10.1002/hep.24809.
PubMed Text format Related articles Abstract available

LANGE CM , Kutalik Z, Morikawa K, Bibert S, et al
Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy.
Hepatology. 2011 Nov 16. doi: 10.1002/hep.24787.
PubMed Text format Related articles Abstract available

HARRINGTON PR , Zeng W, Naeger LK
Clinical relevance of detectable but not quantifiable hepatitis C virus RNA during boceprevir or telaprevir treatment.
Hepatology. 2011 Nov 16. doi: 10.1002/hep.24791.
PubMed Text format Related articles Abstract available

GUEDJ J , Dahari H, Shudo E, Smith P, et al
Hepatitis C viral kinetics with the nucleoside polymerase inhibitor mericitabine (RG7128).
Hepatology. 2011 Nov 16. doi: 10.1002/hep.24788.
PubMed Text format Related articles Abstract available

LIAW YF , Jia JD, Chan HL, Han KH, et al
Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C.
Hepatology. 2011;54:1591-9.
PubMed Text format Related articles Abstract available

INNES HA , Hutchinson SJ, Allen S, Bhattacharyya D, et al
Excess liver-related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from care.
Hepatology. 2011;54:1547-1558.
PubMed Text format Related articles Abstract available

MUIR AJ , Poordad FF, McHutchison JG, Shiffman ML, et al
Retreatment with telaprevir combination therapy in hepatitis C patients with well-characterized prior treatment response.
Hepatology. 2011;54:1538-46.
PubMed Text format Related articles Abstract available

GHANY MG , Kim HY, Stoddard A, Wright EC, et al
Predicting clinical outcomes using baseline and follow-up laboratory data from the hepatitis C long-term treatment against cirrhosis trial.
Hepatology. 2011;54:1527-1537.
PubMed Text format Related articles Abstract available

HELBIG KJ , Eyre NS, Yip E, Narayana S, et al
The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A.
Hepatology. 2011;54:1506-17.
PubMed Text format Related articles Abstract available

CHARLTON M
Boceprevir (Victrelis) for HCV: V is for victory and very complex.
Hepatology. 2011;54:1882-6.
PubMed Text format Related articles

WOOD NA , Linn ML, Bowen DG
Exhausted or just sleeping: Awakening virus-specific responses in chronic hepatitis C virus infection.
Hepatology. 2011;54:1879-82.
PubMed Text format Related articles

GORRELL MD , Zekry A, McCaughan GW, Lloyd A, et al
The long and the short of interferon-gamma-inducible protein 10 in hepatitis C virus infection.
Hepatology. 2011;54:1875-9.
PubMed Text format Related articles

ZEISEL MB , Da Costa D, Baumert TF
Opening the door for hepatitis C virus infection in genetically humanized mice.
Hepatology. 2011;54:1873-5.
PubMed Text format Related articles

October 2011

FUJIWARA K , Yokosuka O
Histological discrimination between autoimmune hepatitis and drug-induced liver injury.
Hepatology. 2011 Oct 31. doi: 10.1002/hep.24768.
PubMed Text format Related articles

LUTGEHETMANN M , Mancke LV, Volz T, Helbig M, et al
Human chimeric uPA mouse model to study hepatitis B and D virus interactions and preclinical drug evaluation.
Hepatology. 2011 Oct 26. doi: 10.1002/hep.24758.
PubMed Text format Related articles Abstract available

GREBELY J , Pham ST, Matthews GV, Petoumenos K, et al
Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection.
Hepatology. 2011 Oct 26. doi: 10.1002/hep.24754.
PubMed Text format Related articles Abstract available

EVERSON GT , Shiffman ML, Hoefs JC, Morgan TR, et al
Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: Results from the HALT-C trial.
Hepatology. 2011 Oct 26. doi: 10.1002/hep.24752.
PubMed Text format Related articles Abstract available

LI K , Li NL, Wei D, Pfeffer SR, et al
Activation of chemokine and inflammatory cytokine response in HCV-infected hepatocytes depends on TLR3 sensing of HCV dsRNA intermediates.
Hepatology. 2011 Oct 26. doi: 10.1002/hep.24763.
PubMed Text format Related articles Abstract available

ZEUZEM S , Buggisch P, Agarwal K, Marcellin P, et al
The protease inhibitor GS-9256 and non-nucleoside polymerase inhibitor tegobuvir alone, with RBV or peginterferon plus RBV in hepatitis C.
Hepatology. 2011 Oct 17. doi: 10.1002/hep.24744.
PubMed Text format Related articles Abstract available

CHAYAMA K , Takahashi S, Toyota J, Karino Y, et al
Dual therapy with the NS5A inhibitor BMS-790052 and the NS3 protease inhibitor BMS-650032 in HCV genotype 1b-infected null responders.
Hepatology. 2011 Oct 10. doi: 10.1002/hep.24724.
PubMed Text format Related articles Abstract available

HOULIHAN D , Hopkins L, Suresh S, Armstrong M, et al
Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short-term and long-term outcomes.
Hepatology. 2011 Oct 10. doi: 10.1002/hep.24722.
PubMed Text format Related articles

DAO DY , Hynan LS, Yuan HJ, Sanders C, et al
Two distinct subtypes of hepatitis B virus-related acute liver ailure are separable by uantitative serum IgM anti-HBc and HBV DNA levels.
Hepatology. 2011 Oct 10. doi: 10.1002/hep.24732.
PubMed Text format Related articles Abstract available

SUN L , Zhang JC, Zhao J
Acute fulminant hepatitis with bone marrow failure in an adult due to parvovirus B19 infection.
Hepatology. 2011 Oct 3. doi: 10.1002/hep.24720.
PubMed Text format Related articles

KROY DC , Lauer GM
Hepatitis B virus infection: A strong case against ageism.
Hepatology. 2011;54:1477-9.
PubMed Text format Related articles

MCCARTNEY EM , Eyre NS, Beard MR
Border patrol intensifies for hepatitis C virus entry.
Hepatology. 2011;54:1472-5.
PubMed Text format Related articles

RINELLA ME
Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease?
Hepatology. 2011;54:1118-20.
PubMed Text format Related articles

HAN Q , Zhang C, Zhang J, Tian Z, et al
Reversal of hepatitis B virus-induced immune tolerance by an immunostimulatory 3p-HBx-siRNAs in a retinoic acid inducible gene I-dependent manner.
Hepatology. 2011;54:1179-89.
PubMed Text format Related articles Abstract available

NEUMANN-HAEFELIN C , Oniangue-Ndza C, Kuntzen T, Schmidt J, et al
Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutations.
Hepatology. 2011;54:1157-66.
PubMed Text format Related articles Abstract available

MATO JM , Lu SC
Where are we in the search for noninvasive nonalcoholic steatohepatitis biomarkers?
Hepatology. 2011;54:1115-7.
PubMed Text format Related articles

September 2011

MEULEMAN P , Catanese MT, Verhoye L, Desombere I, et al
A human monoclonal antibody targeting SR-BI precludes hepatitis C virus infection and viral spread in vitro and in vivo.
Hepatology. 2011 Sep 27. doi: 10.1002/hep.24692.
PubMed Text format Related articles Abstract available

SCHULZE A , Mills K, Weiss TS, Urban S, et al
Hepatocyte polarization is essential for the productive entry of the hepatitis B virus.
Hepatology. 2011 Sep 27. doi: 10.1002/hep.24707.
PubMed Text format Related articles Abstract available

TACKE R , Lee HC, Goh C, Courtney J, et al
Myeloid suppressor cells induced by hepatitis C virus suppress T cell responses through the production of reactive oxygen species.
Hepatology. 2011 Sep 27. doi: 10.1002/hep.24700.
PubMed Text format Related articles Abstract available

DE NICOLA S , Aghemo A, Rumi MG, Galmozzi E, et al
An IL28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis c genotype 4.
Hepatology. 2011 Sep 19. doi: 10.1002/hep.24683.
PubMed Text format Related articles Abstract available

AMET T , Ghabril M, Chalasani N, Byrd D, et al
CD59 incorporation protects hepatitis C virus against complement-mediated destruction.
Hepatology. 2011 Sep 19. doi: 10.1002/hep.24686.
PubMed Text format Related articles Abstract available

SANDRA B , F SA, Karoline R, Judith M, et al
Treatment of chronic hepatitis C GT 1 patients at an academic center in europe involved in prospective controlled trials - is there a selection bias?
Hepatology. 2011 Sep 19. doi: 10.1002/hep.24671.
PubMed Text format Related articles Abstract available

AGGARWAL R , Jameel S
Hepatitis E.
Hepatology. 2011 Sep 19. doi: 10.1002/hep.24674.
PubMed Text format Related articles Abstract available

DOI H , Iyer TK, Carpenter E, Li H, et al
Dysfunctional B-cell activation in cirrhosis due to hepatitis C infection associated with disappearance of CD27+ B-cell population.
Hepatology. 2011 Sep 19. doi: 10.1002/hep.24689.
PubMed Text format Related articles Abstract available

BOCHUD PY , Bibert S, Kutalik Z, Patin E, et al
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes.
Hepatology. 2011 Sep 19. doi: 10.1002/hep.24678.
PubMed Text format Related articles Abstract available

WANG MY
Liver infarction after TIPS in a liver transplant recipient.
Hepatology. 2011 Sep 19. doi: 10.1002/hep.24672.
PubMed Text format Related articles

CORIAT R , Mir O, Goldwasser F, Pol S, et al
Targeting angiogenesis in chronic liver diseases with portal hypertension: anti-PlGF inhibitor or multikinase inhibitor sorafenib?
Hepatology. 2011 Sep 19. doi: 10.1002/hep.24688.
PubMed Text format Related articles

D'AVOLIO A , Ciancio A, Siccardi M, Baietto L, et al
Ribavirin pharmacokinetics and IL28B plus CYP27B1 SNPs as predictors of response to Peg-IFN/RBV treatment in HCV 1/4 infected patients.
Hepatology. 2011 Sep 6. doi: 10.1002/hep.24636.
PubMed Text format Related articles

MARTIN NK , Vickerman P, Miners A, Foster GR, et al
The cost-effectiveness of HCV antiviral treatment for injecting drug user populations.
Hepatology. 2011 Sep 2. doi: 10.1002/hep.24656.
PubMed Text format Related articles Abstract available

BOURSIER J , de Ledinghen V, Zarski JP, Fouchard-Hubert I, et al
Comparison of 8 diagnostic algorithms for liver fibrosis in hepatitis C: New algorithms are more precise and entirely non-invasive.
Hepatology. 2011 Sep 2. doi: 10.1002/hep.24654.
PubMed Text format Related articles Abstract available

JAZAYERI SM , Alavian SM
Commentary on emergence of hepatitis B virus S gene mutants in patients experiencing HBsAg seroconversion after peginterferon therapy.
Hepatology. 2011 Sep 2. doi: 10.1002/hep.24650.
PubMed Text format Related articles

WU C , Gilroy R, Taylor R, Olyaee M, et al
Alteration of hepatic nuclear receptor-mediated signaling pathways in HCV patients with and without a history of alcohol drinking.
Hepatology. 2011 Sep 2. doi: 10.1002/hep.24645.
PubMed Text format Related articles Abstract available

GHANY M , Nelson DR, Strader DB, Thomas DL, et al
An update on treatment of genotype 1 chronic hepatitis c virus infection: 2011 practice guidelines by the american association for the study of liver diseases.
Hepatology. 2011 Sep 2. doi: 10.1002/hep.24641.
PubMed Text format Related articles

LEISE MD , Kim WR, Canterbury KM, Poterucha JJ, et al
Diagnostic and therapeutic advances in hepatology.
Hepatology. 2011 Sep 2. doi: 10.1002/hep.24660.
PubMed Text format Related articles

August 2011

EDLICH B , Ahlenstiel G, Azpiroz AZ, Stoltzfus J, et al
Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C.
Hepatology. 2011 Aug 24. doi: 10.1002/hep.24628.
PubMed Text format Related articles Abstract available

SYED GH , Siddiqui A
Effects of hypolipidemic agent nordihydroguaiaretic acid on lipid droplets and hepatitis C virus.
Hepatology. 2011 Aug 19. doi: 10.1002/hep.24619.
PubMed Text format Related articles Abstract available

WHITE DL , Tavakoli-Tabasi S, Kuzniarek J, Pascua R, et al
Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males.
Hepatology. 2011 Aug 19. doi: 10.1002/hep.24618.
PubMed Text format Related articles Abstract available

CIESEK S , von Hahn T, Colpitts CC, Schang LM, et al
The green tea polyphenol epigallocatechin-3-gallate (EGCG) inhibits hepatitis C virus (HCV) entry.
Hepatology. 2011 Aug 11. doi: 10.1002/hep.24610.
PubMed Text format Related articles Abstract available

NETTLES RE , Gao M, Bifano M, Chung E, et al
Multiple ascending dose study of BMS-790052, an NS5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1.
Hepatology. 2011 Aug 11. doi: 10.1002/hep.24609.
PubMed Text format Related articles Abstract available

PARIS AJ , Snapir Z, Christopherson CD, Kwok SY, et al
A polymorphism that delays fibrosis in hepatitis C promotes alternative splicing of AZIN1, reducing fibrogenesis.
Hepatology. 2011 Aug 11. doi: 10.1002/hep.24608.
PubMed Text format Related articles Abstract available

VALENTI L , Fargion S
PNPLA3 I148M and fibrosis progression after liver transplantation.
Hepatology. 2011 Aug 11. doi: 10.1002/hep.24601.
PubMed Text format Related articles

LIAW YF
Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: A review.
Hepatology. 2011;54:E1-9.
PubMed Text format Related articles Abstract available

FRIDELL RA , Wang C, Sun JH, O' Boyle DR 2nd, et al
Genotypic and phenotypic analysis of variants resistant to HCV NS5A replication complex inhibitor BMS-790052: In Vitro and In Vivo correlations.
Hepatology. 2011 Aug 1. doi: 10.1002/hep.24594.
PubMed Text format Related articles Abstract available

SENIOR JR , Thomas London W, Sutnick AI
The australia antigen, role of the late philadelphia general hospital in reducing post-transfusion hepatitis, and sequelae.
Hepatology. 2011 Aug 1. doi: 10.1002/hep.24593.
PubMed Text format Related articles

LIU T , Zhang C, Wang Y
Proper antiviral therapy for hepatitis B virus-associated acute-on-chronic liver failure.
Hepatology. 2011;54:747-8.
PubMed Text format Related articles

July 2011

MARTINOT-PEIGNOUX M , Asselah T, Marcellin P
HEP-09-1639.R1 correspondence invitation Twelve weeks post-treatment follow-up is as relevant as 24 weeks to determine the SVR in patients with HCV receiving PEG-IFN and ribavirin.
Hepatology. 2011 Jul 28. doi: 10.1002/hep.24585.
PubMed Text format Related articles

MARUKIAN S , Andrus L, Sheahan TP, Jones CT, et al
Hepatitis C virus induces interferon-lambda and interferon-stimulated genes in primary liver cultures.
Hepatology. 2011 Jul 28. doi: 10.1002/hep.24580.
PubMed Text format Related articles Abstract available

CHOI SS , Bradrick S, Qiang G, Mostafavi A, et al
Upregulation of Hedgehog pathway is associated with cellular permissiveness for hepatitis C virus replication.
Hepatology. 2011 Jul 25. doi: 10.1002/hep.24576.
PubMed Text format Related articles Abstract available

GAL-TANAMY M , Bachmetov L, Ravid A, Koren R, et al
Vitamin-D: An innate antiviral agent suppressing Hepatitis C virus in human hepatocytes.
Hepatology. 2011 Jul 25. doi: 10.1002/hep.24575.
PubMed Text format Related articles Abstract available

DO O NT , Eurich D, Trautwein C, Neuhaus P, et al
The common I148 M variant of PNPLA3 does not predict fibrosis progression after liver transplantation for hepatitis C.
Hepatology. 2011 Jul 11. doi: 10.1002/hep.24535.
PubMed Text format Related articles

ROCKENBACH G , De Melo Neto AJ, Barcellos NT, Wolff FH, et al
Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection.
Hepatology. 2011 Jul 11. doi: 10.1002/hep.24533.
PubMed Text format Related articles

WONG DK , Huang FY, Lai CL, Poon RT, et al
Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma.
Hepatology. 2011 Jul 11. doi: 10.1002/hep.24551.
PubMed Text format Related articles Abstract available

GOLDEN-MASON L , Bambha KM, Cheng L, Howell CD, et al
Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C.
Hepatology. 2011 Jul 11. doi: 10.1002/hep.24556.
PubMed Text format Related articles Abstract available

SCHERZER TM , Friedrich Stattermayer A, Strasser M, Laferl H, et al
Impact of IL28B on treatment outcome in HCV G1/4 patients receiving response-guided therapy with peginterferon alfa-2a (40KD)/ ribavirin.
Hepatology. 2011 Jul 11. doi: 10.1002/hep.24546.
PubMed Text format Related articles Abstract available

TENG CF , Wu HC, Tsai HW, Shiah HS, et al
Novel feedback inhibition of surface antigen synthesis by mTOR signal and its implication for hepatitis B virus tumorigenesis and therapy.
Hepatology. 2011 Jul 6. doi: 10.1002/hep.24529.
PubMed Text format Related articles Abstract available

SHIRE AM , Roberts LR
Occult hepatitis B virus infection: Bit player or role player.
Hepatology. 2011 Jul 6. doi: 10.1002/hep.24528.
PubMed Text format Related articles

MAZUMDAR B , Banerjee A, Meyer K, Ray R, et al
Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes.
Hepatology. 2011 Jul 6. doi: 10.1002/hep.24523.
PubMed Text format Related articles Abstract available

SUGIMOTO K , Ito T, Yamamoto N, Katsuya S, et al
Seven cases of autoimmune hepatitis that developed after drug-induced liver injury.
Hepatology. 2011 Jul 2. doi: 10.1002/hep.24513.
PubMed Text format Related articles

KANDA T , Imazeki F, Wu S, Nakamoto S, et al
The assessment of serum HCV RNA 12 weeks after the end of treatment using TaqMan PCR is less relevant than after 24 weeks for predicting SVR.
Hepatology. 2011 Jul 2. doi: 10.1002/hep.24512.
PubMed Text format Related articles

YOUNOSSI ZM , Stepanova M
Changes in hepatitis A and B vaccination rates in adult patients with chronic liver diseases and diabetes in the united states population.
Hepatology. 2011 Jul 2. doi: 10.1002/hep.24510.
PubMed Text format Related articles Abstract available

LIM LY , Kwo PY
A glimpse at the future of hepatitis C therapy: The INFORM trial.
Hepatology. 2011;54:360-3.
PubMed Text format Related articles

CHARLTON M
Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents--a potentially lethal cocktail.
Hepatology. 2011;54:3-5.
PubMed Text format Related articles

GARG V , van Heeswijk R, Lee JE, Alves K, et al
Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus.
Hepatology. 2011;54:20-7.
PubMed Text format Related articles Abstract available

PATEL SM , Sweetser S
The wet-ascitic form of tuberculous peritonitis.
Hepatology. 2011;54:364-5.
PubMed Text format Related articles

PARK O , Wang H, Weng H, Feigenbaum L, et al
In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression.
Hepatology. 2011;54:252-61.
PubMed Text format Related articles Abstract available

June 2011

MARABITA F , Aghemo A, De Nicola S, Rumi MG, et al
Genetic variation in IL28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection.
Hepatology. 2011 Jun 30. doi: 10.1002/hep.24503.
PubMed Text format Related articles Abstract available

HUI KL , Ee Chee R
Novel PARP1 binding motif in hepatitis B virus core promoter impairs DNA damage repair.
Hepatology. 2011 Jun 30. doi: 10.1002/hep.24502.
PubMed Text format Related articles Abstract available

CHEN DS
Fighting against viral hepatitis: Lessons from Taiwan.
Hepatology. 2011 Jun 30. doi: 10.1002/hep.24500.
PubMed Text format Related articles Abstract available

RIDRUEJO E , Adrover R, Silva MO
Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice.
Hepatology. 2011 Jun 30. doi: 10.1002/hep.24498.
PubMed Text format Related articles

BHALA N , Angulo P, van der Poorten D, Lee E, et al
The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study.
Hepatology. 2011 Jun 17. doi: 10.1002/hep.24491.
PubMed Text format Related articles Abstract available

BARTH H , Rybczynska J, Patient R, Choi Y, et al
Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees.
Hepatology. 2011 Jun 14. doi: 10.1002/hep.24489.
PubMed Text format Related articles Abstract available

INDOLFI G , Sambrotta M, Moriondo M, Azzari C, et al
Genetic variation in IL28B locus is associated with spontaneous clearance of HCV in children with Non-1 viral genotype infection.
Hepatology. 2011 Jun 14. doi: 10.1002/hep.24482.
PubMed Text format Related articles

SUZUKI A , Brunt EM, Kleiner DE, Miquel R, et al
The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis vs. drug-induced liver injury.
Hepatology. 2011 Jun 14. doi: 10.1002/hep.24481.
PubMed Text format Related articles Abstract available

DI MARTINO V , Richou C, Cervoni JP, Sanchez-Tapias JM, et al
Response-guided Peg-interferon plus ribavirin treatment duration in chronic hepatitis C: Meta-analyses of randomized controlled trials and implications for the future.
Hepatology. 2011 Jun 14. doi: 10.1002/hep.24480.
PubMed Text format Related articles Abstract available

YU HC , Hsu YH, Hu CT
A woman with improving cholestasis but hepatitis aggravating.
Hepatology. 2011;53:2137-8.
PubMed Text format Related articles

LUTZ HH , Trautwein C
Reviving pegylated interferon as a therapeutic agent for hepatitis D: No more room for nucleos(t)ides?
Hepatology. 2011;53:2131-4.
PubMed Text format Related articles

HONGTHANAKORN C , Chotiyaputta W, Oberhelman K, Fontana RJ, et al
Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice.
Hepatology. 2011;53:1854-63.
PubMed Text format Related articles Abstract available

ARONSOHN A , Jensen D
Distributive justice and the arrival of direct-acting antivirals: who should be first in line?
Hepatology. 2011;53:1789-91.
PubMed Text format Related articles

FIORAVANTI J , Gonzalez I, Medina-Echeverz J, Larrea E, et al
Anchoring interferon alpha to apolipoprotein A-I reduces hematological toxicity while enhancing immunostimulatory properties.
Hepatology. 2011;53:1864-73.
PubMed Text format Related articles Abstract available

May 2011

PENG ZG , You XF, Jiang JD
Editing enzyme human APOBEC3G (hA3G) could be a promising therapeutic target for hepatitis C virus (HCV) drug discovery.
Hepatology. 2011 May 29. doi: 10.1002/hep.24462.
PubMed Text format Related articles

HIRAGA N , Imamura M, Abe H, Nelson Hayes C, et al
Rapid emergence of telaprevir resistant hepatitis C virus strain from wild type clone in vivo.
Hepatology. 2011 May 29. doi: 10.1002/hep.24460.
PubMed Text format Related articles Abstract available

HIRAGA N , Abe H, Imamura M, Tsuge M, et al
Impact of viral amino acid substitutions and host IL28B polymorphism on replication and susceptibility to interferon of hepatitis C virus.
Hepatology. 2011 May 26. doi: 10.1002/hep.24453.
PubMed Text format Related articles Abstract available

GUO X , Johnson R, O'Brien SJ
Response to Dr. Liu letter on "association between (HLA)-DP gene polymorphisms and chronic hepatitis B in a Chinese population" (MS ID: HEP-11-0735).
Hepatology. 2011 May 26. doi: 10.1002/hep.24448.
PubMed Text format Related articles

JI HF
Vitamin D levels may explain the racial differences in response rates to antiviral therapy of chronic hepatitis C.
Hepatology. 2011 May 26. doi: 10.1002/hep.24447.
PubMed Text format Related articles

MCMAHON BJ , Bulkow LR, Singleton RJ, Williams J, et al
Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program.
Hepatology. 2011 May 26. doi: 10.1002/hep.24442.
PubMed Text format Related articles Abstract available

GUO H , Liu H, Mitchelson K, Rao H, et al
MicroRNAs-372/373 promote the expression of hepatitis B Virus through the targeting of nuclear factor I/B.
Hepatology. 2011 May 23. doi: 10.1002/hep.24441.
PubMed Text format Related articles Abstract available

GARG H , Sarin SK, Kumar M, Garg V, et al
The ethics of placebo treatment for patients with acute exacerbation of chronic hepatitis B "tenofovir in the management of patients with ACLF due to HBV reactivation"
Hepatology. 2011 May 23. doi: 10.1002/hep.24438.
PubMed Text format Related articles

COPPOLA N , Pisaturo M, Guastafierro S, Tonziello G, et al
Absence of occult HCV infection in patients under immunosupressive therapy for oncohematological diseases.
Hepatology. 2011 May 23. doi: 10.1002/hep.24436.
PubMed Text format Related articles

PENG L , Xie DY, Lin BL, Liu J, et al
Autologous bone mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short-term and long-term outcomes.
Hepatology. 2011 May 23. doi: 10.1002/hep.24434.
PubMed Text format Related articles Abstract available

KALAMBOKIS GN , Tsianos EV
Raised sympathetic activity and blood ammonia could increase sensitivity to infections in patients with cirrhosis and refractory ascites on beta-blockers.
Hepatology. 2011 May 23. doi: 10.1002/hep.24439.
PubMed Text format Related articles

MOSCHEN AR , Gerner R, Schroll A, Fritz T, et al
A key role for pre-B-cell colony-enhancing factor in experimental hepatitis.
Hepatology. 2011 May 12. doi: 10.1002/hep.24416.
PubMed Text format Related articles Abstract available

LIU C
Association between (HLA)-DP gene polymorphisms and chronic hepatitis B in a Chinese population.
Hepatology. 2011 May 11. doi: 10.1002/hep.24411.
PubMed Text format Related articles

ALISI A , Tomaselli S, Balsano C, Gallo A, et al
Hepatitis C virus (HCV) therapeutics: Editing enzymes promising therapeutic targets?
Hepatology. 2011 May 11. doi: 10.1002/hep.24409.
PubMed Text format Related articles

ZOUTENDIJK R , Reijnders JG, Brown A, Zoulim F, et al
Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naive patients with a partial virological response.
Hepatology. 2011 May 11. doi: 10.1002/hep.24406.
PubMed Text format Related articles Abstract available

NGUYEN D , Talwalkar JA
Diagnostic and therapeutic advances in Hepatology noninvasive assessment of liver fibrosis.
Hepatology. 2011 May 5. doi: 10.1002/hep.24401.
PubMed Text format Related articles

DAI CY , Huang CF, Huang JF, Chuang WL, et al
Association between virological response and decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in HCV genotype 1: another story.
Hepatology. 2011;53:1774-5.
PubMed Text format Related articles

LEE JM , Ahn SH, Kim HS, Park H, et al
Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir.
Hepatology. 2011;53:1486-93.
PubMed Text format Related articles

ZHANG X , Zhang E, Ma Z, Pei R, et al
Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1.
Hepatology. 2011;53:1476-85.
PubMed Text format Related articles

STEENKISTE CV , Ribera J, Geerts A, Pauta M, et al
Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice.
Hepatology. 2011;53:1629-40.
PubMed Text format Related articles

DARA L , Ji C, Kaplowitz N
The contribution of endoplasmic reticulum stress to liver diseases.
Hepatology. 2011;53:1752-63.
PubMed Text format Related articles Abstract available

SCHURICH A , Khanna P, Lopes AR, Han KJ, et al
Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection.
Hepatology. 2011;53:1494-503.
PubMed Text format Related articles Abstract available

RODRIGUE JR , Balistreri W, Haber B, Jonas MM, et al
Peginterferon with or without ribavirin has minimal effect on quality of life, behavioral/emotional, and cognitive outcomes in children.
Hepatology. 2011;53:1468-75.
PubMed Text format Related articles Abstract available

April 2011

SAEED M , Shiina M, Date T, Akazawa D, et al
In Vivo adaptation of hepatitis C virus for efficient virus production and evasion of apoptosis.
Hepatology. 2011 Apr 29. doi: 10.1002/hep.24399.
PubMed Text format Related articles

LO GH
The ethics of placebo treatment for patients with acute exacerbation of chronic hepatitis B.
Hepatology. 2011 Apr 29. doi: 10.1002/hep.24392.
PubMed Text format Related articles

LAI JC , Verna EC, Brown RS Jr, O'Leary JG, et al
Hepatitis C virus infected females have a higher risk of advanced fibrosis and graft loss after liver transplantation than males.
Hepatology. 2011 Apr 28. doi: 10.1002/hep.24390.
PubMed Text format Related articles

NDONGO-THIAM N , Berthillon P, Errazuriz E, Bordes I, et al
Long-term propagation of serum hepatitis C virus with production of enveloped HCV particles in human HepaRG hepatocytes.
Hepatology. 2011 Apr 21. doi: 10.1002/hep.24386.
PubMed Text format Related articles

RAIMONDO G , Pollicino T, Levrero M, Craxi A, et al
Occult hepatitis B virus infection and hepatocellular carcinoma development in patients with chronic hepatitis C.
Hepatology. 2011 Apr 21. doi: 10.1002/hep.24379.
PubMed Text format Related articles

FOSTER TL , Verow M, Wozniak AL, Bentham MJ, et al
Resistance mutations define specific antiviral effects for inhibitors of the hepatitis C virus (HCV) p7 ion channel.
Hepatology. 2011 Apr 21. doi: 10.1002/hep.24371.
PubMed Text format Related articles

DIENSTAG JL , Ghany MG, Morgan TR, Di Bisceglie AM, et al
A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C (HEP-10-2210).
Hepatology. 2011 Apr 21. doi: 10.1002/hep.24370.
PubMed Text format Related articles

EHRHARDT M , Leidinger P, Keller A, Baumert TF, et al
Profound differences of miRNA expression patterns in hepatocytes and hepatoma cell lines commonly used in HCV studies.
Hepatology. 2011 Apr 18. doi: 10.1002/hep.24366.
PubMed Text format Related articles

LIAW YF
The clinical utility of HBsAg quantitation in chronic hepatitis B patients: A review.
Hepatology. 2011 Apr 18. doi: 10.1002/hep.24364.
PubMed Text format Related articles Abstract available

HSU CW , Yeh CT
Emergence of hepatitis B virus S gene mutants in patients experiencing HBsAg seroconversion after peginterferon therapy.
Hepatology. 2011 Apr 18. doi: 10.1002/hep.24363.
PubMed Text format Related articles Abstract available

ZHOU J , Tan T, Tian Y, Zheng B, et al
KLF15 activates hepatitis B virus gene expression and replication.
Hepatology. 2011 Apr 18. doi: 10.1002/hep.24362.
PubMed Text format Related articles

LIAW YF , Raptopoulou-Gigi M, Cheinquer H, Sarin SK, et al
Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized open-label study.
Hepatology. 2011 Apr 18. doi: 10.1002/hep.24361.
PubMed Text format Related articles Abstract available

MELIA MT , Muir AJ, McCone J, Shiffman ML, et al
Racial differences in hepatitis C treatment eligibility.
Hepatology. 2011 Apr 12. doi: 10.1002/hep.24358.
PubMed Text format Related articles Abstract available

TREPO E , Pradat P, Potthoff A, Momozawa Y, et al
Impact of PNPLA3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C.
Hepatology. 2011 Apr 12. doi: 10.1002/hep.24350.
PubMed Text format Related articles Abstract available

WAGNER F , Thompson R, Kantaridis C, Simpson P, et al
Antiviral activity of the hepatitis C virus polymerase inhibitor filibuvir in genotype 1 infected patients.
Hepatology. 2011 Apr 12. doi: 10.1002/hep.24342.
PubMed Text format Related articles Abstract available

XIN YN , Lin ZH, Xuan SY
Are there more factors other than hepatitis B virus-DNA level and A1762T/G1764A mutation in liver tissue that also independently predict postoperative survival in hepatocellular carcinoma?
Hepatology. 2011 Apr 5. doi: 10.1002/hep.24211.
PubMed Text format Related articles

CLEMENT S , Peyrou M, Sanchez-Pareja A, Bourgoin L, et al
Downregulation of PTEN and IRS-1 by HCV 3a core protein triggers the formation of large lipid droplets in hepatocytes.
Hepatology. 2011 Apr 4. doi: 10.1002/hep.24340.
PubMed Text format Related articles Abstract available

ZUR WIESCH JS , Pudelski N, Hoepner L, Supplieth M, et al
"Real-Life" comparison of pegylated-interferon 2a versus 2b combination therapy of chronic hepatitis C virus.
Hepatology. 2011;53:1453-4.
PubMed Text format Related articles

LOFTIS JM , Morasco BJ, Hauser P
Depression and antiviral response to interferon-based therapy for hepatitis C virus infection.
Hepatology. 2011;53:1413-4.
PubMed Text format Related articles

GIANNI T , Paolo B
Hepatitis C recurrence: Influence of serum cholesterol levels and liver steatosis on antiviral therapy.
Hepatology. 2011;53:1409-10.
PubMed Text format Related articles

YU ML
The importance of the definition of early virological response for predicting treatment efficacy for chronic hepatitis C.
Hepatology. 2011;53:1403.
PubMed Text format Related articles

DAI CY , Yeh ML, Huang JF, Chuang WL, et al
Insurance status and treatment candidacy of patients with hepatitis C: Taiwanese patients are luckier.
Hepatology. 2011;53:1399.
PubMed Text format Related articles

CASPER M , Grunhage F, Lammert F
Cancer risk in chronic hepatitis B: Do genome-wide association studies hit the mark?
Hepatology. 2011;53:1390-2.
PubMed Text format Related articles Abstract available

OHISHI W , Fujiwara S, Cologne JB, Suzuki G, et al
Impact of radiation and hepatitis virus infection on risk of hepatocellular carcinoma.
Hepatology. 2011;53:1237-45.
PubMed Text format Related articles Abstract available

FWU CW , Chien YC, You SL, Nelson KE, et al
Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: A cohort study of parous women in Taiwan.
Hepatology. 2011;53:1217-25.
PubMed Text format Related articles Abstract available

FUNG J , Lai CL, Yuen J, Cheng C, et al
Randomized trial of lamivudine versus entecavir in entecavir-treated patients with undetectable hepatitis B virus DNA: Outcome at 2 Years.
Hepatology. 2011;53:1148-53.
PubMed Text format Related articles Abstract available

WANG WH , Studach LL, Andrisani OM
Proteins ZNF198 and SUZ12 are down-regulated in hepatitis B virus (HBV) X protein-mediated hepatocyte transformation and in HBV replication.
Hepatology. 2011;53:1137-47.
PubMed Text format Related articles Abstract available

PFANNKUCHE A , Buther K, Karthe J, Poenisch M, et al
C-Src is required for complex formation between the hepatitis C virus-encoded proteins NS5A and NS5B: A prerequisite for replication.
Hepatology. 2011;53:1127-36.
PubMed Text format Related articles Abstract available

BITETTO D , Fattovich G, Fabris C, Ceriani E, et al
Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C.
Hepatology. 2011;53:1118-26.
PubMed Text format Related articles Abstract available

SIEVERT W , Dore GJ, McCaughan GW, Yoshihara M, et al
Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1.
Hepatology. 2011;53:1109-1117.
PubMed Text format Related articles Abstract available

DI BISCEGLIE AM , Stoddard AM, Dienstag JL, Shiffman ML, et al
Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon.
Hepatology. 2011;53:1100-1108.
PubMed Text format Related articles Abstract available

IMHOF I , Simmonds P
Genotype differences in susceptibility and resistance development of hepatitis C virus to protease inhibitors telaprevir (VX-950) and danoprevir (ITMN-191).
Hepatology. 2011;53:1090-9.
PubMed Text format Related articles Abstract available

PENG ZG , Zhao ZY, Li YP, Wang YP, et al
Host apolipoprotein b messenger RNA-editing enzyme catalytic polypeptide-like 3G is an innate defensive factor and drug target against hepatitis C virus.
Hepatology. 2011;53:1080-9.
PubMed Text format Related articles Abstract available

ALBERT ML , Casrouge A, Chevaliez S, Hezode C, et al
Interferon induced protein 10 remains a useful biomarker of treatment failure in patients stratified for the interleukin-28B rs12979860 haplotype.
Hepatology. 2011;53:1410-1.
PubMed Text format Related articles

PAN Q , Tilanus HW, Janssen HL, van der Laan LJ, et al
Ribavirin enhances interferon-stimulated gene transcription by activation of the interferon-stimulated response element.
Hepatology. 2011;53:1400-1.
PubMed Text format Related articles

MAKOWSKA Z , Duong FH, Trincucci G, Tough DF, et al
Interferon-beta and interferon-lambda signaling is not affected by interferon-induced refractoriness to interferon-alpha in vivo.
Hepatology. 2011;53:1154-63.
PubMed Text format Related articles Abstract available

March 2011

FUJIWARA K , Yasui S, Yokosuka O
Efforts for making the diagnosis of acute onset autoimmune hepatitis.
Hepatology. 2011 Mar 30. doi: 10.1002/hep.24331.
PubMed Text format Related articles

DAI CY , Yeh ML, Huang CF, Huang JF, et al
The outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure treated with antivirals.
Hepatology. 2011 Mar 30. doi: 10.1002/hep.24328.
PubMed Text format Related articles

PETROVIC D , Stamataki Z, Dempsey E, Golden-Mason L, et al
Hepatitis C virus targets the T cell secretory machinery as a mechanism of immune evasion.
Hepatology. 2011 Mar 30. doi: 10.1002/hep.24327.
PubMed Text format Related articles Abstract available

ECHEVERRIA I , Pereboev A, Silva L, Zabaleta A, et al
Enhanced T-cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells.
Hepatology. 2011 Mar 30. doi: 10.1002/hep.24325.
PubMed Text format Related articles Abstract available

DAHARI H , Guedj J, Perelson AS
Silibinin mode of action(s) against HCV: A controversy yet to be resolved.
Hepatology. 2011 Mar 23. doi: 10.1002/hep.24310.
PubMed Text format Related articles

NGUYEN LH , Ko S, Wong SS, Tran PS, et al
Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection.
Hepatology. 2011 Mar 21. doi: 10.1002/hep.24308.
PubMed Text format Related articles Abstract available

RUIZ-EXTREMERA A , Munoz-Gamez J, Salmeron-Ruiz MA, de Rueda PM, et al
Genetic variation in IL28B with respect to vertical transmission of hepatitis C virus and spontaneous clearance in HCV infected children.
Hepatology. 2011 Mar 16. doi: 10.1002/hep.24298.
PubMed Text format Related articles Abstract available

BENSADOUN P , Rodriguez C, Soulier A, Higgs M, et al
Genetic background of hepatocyte cell lines: Are in vitro hepatitis C virus research data reliable?
Hepatology. 2011 Mar 7. doi: 10.1002/hep.24278.
PubMed Text format Related articles

GUEDJ J , Perelson AS
Second phase HCV RNA decline during telaprevir based therapy increases with drug effectiveness: Implications for treatment duration.
Hepatology. 2011 Mar 7. doi: 10.1002/hep.24272.
PubMed Text format Related articles Abstract available

GAO B , Bertola A
Natural killer cells take two tolls to destruct bile ducts.
Hepatology. 2011 Mar 7. doi: 10.1002/hep.24275.
PubMed Text format Related articles

MOSCHEN AR , Fritz T, Clouston AD, Rebhan I, et al
IL-32: A new proinflammatory cytokine involved in HCV-related liver inflammation and fibrosis.
Hepatology. 2011 Mar 4. doi: 10.1002/hep.24285.
PubMed Text format Related articles Abstract available

PATEL K , Lucas J, Thompson J, Dubois L, et al
High predictive accuracy of an unbiased proteomic profile for sustained virologic response in chronic hepatitis C patients.
Hepatology. 2011 Mar 4. doi: 10.1002/hep.24284.
PubMed Text format Related articles Abstract available

PAWLOTSKY JM
Treatment failure and resistance with direct acting antiviral drugs against hepatitis C virus.
Hepatology. 2011 Mar 3. doi: 10.1002/hep.24262.
PubMed Text format Related articles Abstract available

LOK AS , Everhart JE, Di Bisceglie AM, Kim HY, et al
Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in us patients with chronic hepatitis C.
Hepatology. 2011 Mar 3. doi: 10.1002/hep.24257.
PubMed Text format Related articles Abstract available

LAGGING M , Alsio A, Langeland N, Pedersen C, et al
Early determination of hepatitis C virus RNA may help to decide the duration of therapy for chronic hepatitis C virus genotype 2/3 infection.
Hepatology. 2011;53:1067-8.
PubMed Text format Related articles

AKHAVAN S , Ronsin C, Laperche S, Thibault V, et al
Genotype 4 hepatitis C virus: Beware of false-negative RNA detection.
Hepatology. 2011;53:1066-7.
PubMed Text format Related articles

MATTHEWS GV , Dore GJ
Optimal duration of treatment for acute hepatitis c in human immunodeficiency virus-positive individuals?
Hepatology. 2011;53:1055-6.
PubMed Text format Related articles

PIRATVISUTH T , Marcellin P
Further analysis is required to identify an early stopping rule for peginterferon therapy that is valid for all hepatitis B e antigen-positive patients.
Hepatology. 2011;53:1054-5.
PubMed Text format Related articles

SCHUSTER C , Lefevre M, Baumert TF
Triglyceride synthesis and hepatitis C virus production: Identification of a novel host factor as antiviral target.
Hepatology. 2011;53:1046-8.
PubMed Text format Related articles

YEOMAN AD , Westbrook RH, Zen Y, Maninchedda P, et al
Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis.
Hepatology. 2011;53:926-34.
PubMed Text format Related articles Abstract available

KENG VW , Tschida BR, Bell JB, Largaespada DA, et al
Modeling hepatitis B virus X-induced hepatocellular carcinoma in mice with the sleeping beauty transposon system.
Hepatology. 2011;53:781-90.
PubMed Text format Related articles Abstract available

SNOW-LAMPART A , Chappell B, Curtis M, Zhu Y, et al
No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus.
Hepatology. 2011;53:763-73.
PubMed Text format Related articles Abstract available

MOGHADDAM A , Melum E, Reinton N, Ring-Larsen H, et al
IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection.
Hepatology. 2011;53:746-54.
PubMed Text format Related articles Abstract available

YE LP , Mao XL
Is achievement of sustained virologic response an independent predictor or a cofactor for the development of esophageal varices?
Hepatology. 2011;53:1070-1.
PubMed Text format Related articles

JORGE A M , Hashem B el-S
Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the american association for the study of liver diseases.
Hepatology. 2011;53:1060-1.
PubMed Text format Related articles

BRUIX J , Sherman M
Management of hepatocellular carcinoma: An update.
Hepatology. 2011;53:1020-2.
PubMed Text format Related articles

WAGNER M , Zollner G, Trauner M
Nuclear receptors in liver disease.
Hepatology. 2011;53:1023-34.
PubMed Text format Related articles Abstract available

February 2011

YAN J , Jie Z, Hou L, Wanderley JL, et al
Parenchymal expression of CD40 exacerbates adenovirus-induced hepatitis.
Hepatology. 2011 Feb 28. doi: 10.1002/hep.24270.
PubMed Text format Related articles Abstract available

VALENTI L , Colombo M, Fargion S
PNPLA3 genotype and hepatocellular carcinoma in chronic hepatitis C.
Hepatology. 2011 Feb 28. doi: 10.1002/hep.24265.
PubMed Text format Related articles

DI IULIO J , Ciuffi A, Fitzmaurice K, Kelleher D, et al
Estimating the net contribution of IL28B variation to spontaneous hepatitis C virus clearance.
Hepatology. 2011 Feb 28. doi: 10.1002/hep.24263.
PubMed Text format Related articles Abstract available

CORRADINI SG , Burza MA, Molinaro A, Romeo S, et al
Patatin-like phospholipase domain containing 3 sequence variant and hepatocellular carcinoma.
Hepatology. 2011 Feb 23. doi: 10.1002/hep.24244.
PubMed Text format Related articles

FASSIO E , Landeira G, Longo C, Dominguez N, et al
Risk factors for infection in chronic hepatitis C: A high prevalence of sexual exposure among human immunodeficiency virus-coinfected women.
Hepatology. 2011 Feb 11. doi: 10.1002/hep.24224.
PubMed Text format Related articles

MEDERACKE I , Hahn T
Survival of the fittest: Selection of hepatitis C virus variants during liver graft reinfection.
Hepatology. 2011;53:705-8.
PubMed Text format Related articles

BERRES ML , Trautwein C, Schmeding M, Eurich D, et al
Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection.
Hepatology. 2011;53:596-603.
PubMed Text format Related articles Abstract available

LONGHI MS , Hussain MJ, Kwok WW, Mieli-Vergani G, et al
Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis.
Hepatology. 2011;53:536-47.
PubMed Text format Related articles Abstract available

WEN WH , Chen HL, Ni YH, Hsu HY, et al
Secular trend of the viral genotype distribution in children with chronic hepatitis B virus infection after universal infant immunization.
Hepatology. 2011;53:429-36.
PubMed Text format Related articles Abstract available

GUO X , Zhang Y, Li J, Ma J, et al
Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population.
Hepatology. 2011;53:422-8.
PubMed Text format Related articles Abstract available

SHRIVASTAVA S , Raychoudhuri A, Steele R, Ray R, et al
Knockdown of autophagy enhances the innate immune response in hepatitis C virus-infected hepatocytes.
Hepatology. 2011;53:406-14.
PubMed Text format Related articles Abstract available

VIERLING JM
Autoimmune hepatitis and antigen-specific T regulatory cells: When can we send in the regulators?
Hepatology. 2011;53:385-8.
PubMed Text format Related articles

RONGEY C , Yee HF Jr
From the bedside to the community: comparative effectiveness, health services, and implementation research.
Hepatology. 2011;53:673-7.
PubMed Text format Related articles

STRAVITZ RT , Lefkowitch JH, Fontana RJ, Gershwin ME, et al
Autoimmune acute liver failure: proposed clinical and histological criteria.
Hepatology. 2011;53:517-26.
PubMed Text format Related articles Abstract available

VIBERT E , Duclos-Vallee JC, Ghigna MR, Hoti E, et al
Liver transplantation for hepatocellular carcinoma: The impact of human immunodeficiency virus infection.
Hepatology. 2011;53:475-82.
PubMed Text format Related articles Abstract available

THOMPSON AJ , Santoro R, Piazzolla V, Clark PJ, et al
Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR.
Hepatology. 2011;53:389-95.
PubMed Text format Related articles Abstract available

SUZUKI F , Suzuki Y, Akuta N, Sezaki H, et al
Influence of ITPA polymorphisms on decreases of hemoglobin during treatment with pegylated interferon, ribavirin, and telaprevir.
Hepatology. 2011;53:415-21.
PubMed Text format Related articles Abstract available

January 2011

MEULEMAN P , Bukh J, Verhoye L, Farhoudi A, et al
In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus.
Hepatology. 2011 Jan 11. doi: 10.1002/hep.24171.
PubMed Text format Related articles Abstract available

DI MAMBRO AJ , Parker R, McCune A, Gordon F, et al
In vitro steroid resistance correlates with outcome in severe alcoholic hepatitis.
Hepatology. 2011 Jan 10. doi: 10.1002/hep.24159.
PubMed Text format Related articles Abstract available

SINGAL AK , Jampana SC, Anand BS
Comment on a systematic review of randomized trials of peginterferon alpha-2a versus peginterferon alpha-2b in chronic hepatitis C.
Hepatology. 2011 Jan 10. doi: 10.1002/hep.24165.
PubMed Text format Related articles

CHUNG-FENG H , Chia-Yen D, Jee-Fu H, Wan-Long C, et al
Linkage of the hepatitis C virus genotype and interleukin-28B genetic polymorphisms in Asian patients.
Hepatology. 2011;53:367-8.
PubMed Text format Related articles

AFDHAL NH , McHutchison JG, Zeuzem S, Mangia A, et al
Hepatitis C pharmacogenetics: State of the art in 2010.
Hepatology. 2011;53:336-345.
PubMed Text format Related articles Abstract available

CHARLTON MR , Thompson A, Veldt BJ, Watt K, et al
Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection.
Hepatology. 2011;53:317-24.
PubMed Text format Related articles Abstract available

ZHANG M , Xu S, Han Y, Cao X, et al
Apoptotic cells attenuate fulminant hepatitis by priming Kupffer cells to produce interleukin-10 through membrane-bound TGF-beta.
Hepatology. 2011;53:306-16.
PubMed Text format Related articles Abstract available

KORNEK M , Popov Y, Libermann TA, Afdhal NH, et al
Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells.
Hepatology. 2011;53:230-42.
PubMed Text format Related articles Abstract available

JIN Z , Sun R, Wei H, Gao X, et al
Accelerated liver fibrosis in hepatitis B virus transgenic mice: Involvement of natural killer T cells.
Hepatology. 2011;53:219-29.
PubMed Text format Related articles Abstract available

ZHANG Z , Zhang S, Zou Z, Shi J, et al
Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients.
Hepatology. 2011;53:73-85.
PubMed Text format Related articles Abstract available

LIAW YF , Sheen IS, Lee CM, Akarca US, et al
Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease.
Hepatology. 2011;53:62-72.
PubMed Text format Related articles Abstract available

KRAMER JR , Hachem CY, Kanwal F, Mei M, et al
Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection.
Hepatology. 2011;53:42-52.
PubMed Text format Related articles Abstract available

THOMAS E , Feld JJ, Li Q, Hu Z, et al
Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models.
Hepatology. 2011;53:32-41.
PubMed Text format Related articles Abstract available

DIAZ-VALDES N , Manterola L, Belsue V, Riezu-Boj JI, et al
Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10.
Hepatology. 2011;53:23-31.
PubMed Text format Related articles Abstract available

DARLING JM , Aerssens J, Fanning G, McHutchison JG, et al
Quantitation of pretreatment serum interferon-gamma-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response.
Hepatology. 2011;53:14-22.
PubMed Text format Related articles Abstract available

YU ML , Huang CF, Huang JF, Chang NC, et al
Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients.
Hepatology. 2011;53:7-13.
PubMed Text format Related articles Abstract available

TAM J , Liu J, Mukhopadhyay B, Cinar R, et al
Endocannabinoids in liver disease.
Hepatology. 2011;53:346-55.
PubMed Text format Related articles Abstract available

MARTINEZ SM , Crespo G, Navasa M, Forns X, et al
Noninvasive assessment of liver fibrosis.
Hepatology. 2011;53:325-35.
PubMed Text format Related articles Abstract available

LINDOR RA , Lindor KD
The value of observational research in liver diseases.
Hepatology. 2011;53:1-3.
PubMed Text format Related articles

December 2010

STEPANOVA M , Kanwal F, El-Serag HB, Younossi ZM, et al
Insurance status and treatment candidacy of hepatitis C patients: Analysis of population-based data from the United States.
Hepatology. 2010 Dec 17. doi: 10.1002/hep.24131.
PubMed Text format Related articles Abstract available

MENSA L , Crespo G, Gastinger MJ, Kabat J, et al
Hepatitis C virus receptors claudin-1 and occludin after liver transplantation and influence on early viral kinetics.
Hepatology. 2010 Dec 14. doi: 10.1002/hep.24110.
PubMed Text format Related articles Abstract available

GARG H , Sarin SK, Kumar M, Garg V, et al
Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure.
Hepatology. 2010 Dec 14. doi: 10.1002/hep.24109.
PubMed Text format Related articles Abstract available

JUNG KS , Kim SU, Ahn SH, Park YN, et al
Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan).
Hepatology. 2010 Dec 14. doi: 10.1002/hep.24121.
PubMed Text format Related articles Abstract available

YOON SM , Gerasimidou D, Kuwahara R, Hytiroglou P, et al
Epithelial cell adhesion molecule (EpCAM) marks hepatocytes newly derived from stem/progenitor cells in humans.
Hepatology. 2010 Dec 14. doi: 10.1002/hep.24122.
PubMed Text format Related articles Abstract available

VALENTI L , Rumi M, Galmozzi E, Aghemo A, et al
Patatin-Like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C.
Hepatology. 2010 Dec 13. doi: 10.1002/hep.24123.
PubMed Text format Related articles Abstract available

LIN ZH , Xin YN, Dong QJ, Wang Q, et al
Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: An updated meta-analysis.
Hepatology. 2010 Dec 7. doi: 10.1002/hep.24105.
PubMed Text format Related articles Abstract available

BERRES ML , Trautwein C, Schmeding M, Eurich D, et al
Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

KERSHENOBICH D , Munoz L, Male R, Gaytan J, et al
Proceed with caution: Peginterferon alpha-2a versus peginterferon alfa-2b in chronic hepatitis C. A systematic review of randomized trials.
Hepatology. 2010;52:2240-1.
PubMed Text format Related articles

GEROLD G , Rice CM, Ploss A
Teaching new tricks to an old foe: murinizing hepatitis C virus.
Hepatology. 2010;52:2233-6.
PubMed Text format Related articles Abstract available

ZHU Z , Wilson AT, Luxon BA, Brown KE, et al
Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: Mechanism for the antiviral effects of heme oxygenase?
Hepatology. 2010;52:1897-905.
PubMed Text format Related articles Abstract available

GEROLD G , Rice CM, Ploss A
Teaching new tricks to an old foe: murinizing hepatitis C virus.
Hepatology. 2010;52:2233-6.
PubMed Text format Related articles Abstract available

MACARON C , Hanouneh IA, Zein NN
Incidence and risk factors of hepatocellular carcinoma in patients with primary biliary cirrhosis.
Hepatology. 2010;52:2240.
PubMed Text format Related articles

November 2010

KENG VW , Tschida BR, Bell JB, Largaespada DA, et al
Modeling hepatitis B virus X-induced hepatocellular carcinoma in mice with the sleeping beauty transposon system.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

SNOW-LAMPART A , Chappell B, Curtis M, Zhu Y, et al
No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

SHRIVASTAVA S , Raychoudhuri A, Steele R, Ray R, et al
Knockdown of autophagy enhances the innate immune response in hepatitis C virus-infected hepatocytes.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

MERANI S , Petrovic D, James I, Chopra A, et al
Effect of immune pressure on hepatitis C virus evolution: Insights from a single-source outbreak.
Hepatology. 2010 Nov 12. doi: 10.1002/hep.24076.
PubMed Text format Related articles Abstract available

LOFTIS JM , Morasco BJ, Hauser P
Depression and antiviral response to interferon-based therapy for hepatitis C virus infection.
Hepatology. 2010.
PubMed Text format Related articles

WEN WH , Chen HL, Ni YH, Hsu HY, et al
Secular trend of the viral genotype distribution in children with chronic hepatitis B virus infection after universal infant immunization.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

LINDH M , Lagging M, Norkrans G, Hellstrand K, et al
Observed and calculated interleukin-28B genotype frequencies in hepatitis C virus infection.
Hepatology. 2010;52:1860-1.
PubMed Text format Related articles

LAM KD , Trinh HN, Do ST, Nguyen TT, et al
Randomized controlled trial of pegylated interferon-alfa 2a and ribavirin in treatment-naive chronic hepatitis C genotype 6.
Hepatology. 2010;52:1573-80.
PubMed Text format Related articles Abstract available

PHAM ST , Bull RA, Bennett JM, Rawlinson WD, et al
Frequent multiple hepatitis C virus infections among injection drug users in a prison setting.
Hepatology. 2010;52:1564-72.
PubMed Text format Related articles Abstract available

DE MATTOS AZ , de Almeida PR, Tovo CV, de Mattos AA, et al
Pegylated interferon and ribavirin in real life: efficacy versus effectiveness.
Hepatology. 2010;52:1867.
PubMed Text format Related articles

October 2010

GUO X , Zhang Y, Li J, Ma J, et al
Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the han Chinese population.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

LONGHI MS , Hussain MJ, Kwok WW, Mieli-Vergani G, et al
Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

TESTINO G , Borro P
Hepatitis C recurrence: Influence of serum cholesterol levels and liver steatosis on antiviral therapy.
Hepatology. 2010.
PubMed Text format Related articles

ZHANG M , Xu S, Han Y, Cao X, et al
Apoptotic cells attenuate fulminant hepatitis by priming Kupffer cells to produce interleukin-10 through membrane-bound TGF-beta
Hepatology. 2010.
PubMed Text format Related articles Abstract available

KRAMER JR , Hachem CY, Kanwal F, Mei M, et al
Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

PEARLMAN BL , Ehleben C
Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virological response.
Hepatology. 2010;52:1519-20.
PubMed Text format Related articles

CZAJA AJ
Putting flesh and polish on autoimmune hepatitis and moving the disease of exclusion to inclusion.
Hepatology. 2010;52:1177-84.
PubMed Text format Related articles Abstract available

MORENO-OTERO R , Trapero-Marugan M, Garcia-Buey L, Garcia-Sancchez A, et al
Drug-induced postinfantile giant cell hepatitis.
Hepatology. 2010.
PubMed Text format Related articles

KWO PY , Vinayek R
The next step for taribavirin.
Hepatology. 2010;52:1185-8.
PubMed Text format Related articles

CRIPPS JG , Wang J, Maria A, Blumenthal I, et al
Type 1 T helper cells induce the accumulation of myeloid-derived suppressor cells in the inflamed Tgfb1 knockout mouse liver.
Hepatology. 2010;52:1350-9.
PubMed Text format Related articles Abstract available

September 2010

BANAUDHA K , Kaliszewski M, Korolnek T, Florea L, et al
MicroRNA silencing of tumor suppressor DLC-1 promotes efficient hepatitis C virus replication in primary human hepatocytes.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

KORNEK M , Popov Y, Libermann TA, Afdhal NH, et al
Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

THOMAS E , Feld JJ, Li Q, Hu Z, et al
Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

JIN Z , Sun R, Wei H, Gao X, et al
Accelerated liver fibrosis in hepatitis B virus transgenic mice: Involvement of natural killer T cells.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

DIAZ-VALDES N , Manterola L, Belsue V, Riezu-Boj JI, et al
Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

ZHANG Z , Zhang S, Zou Z, Shi J, et al
Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

AKHAVAN S , Ronsin C, Laperche S, Thibault V, et al
Genotype 4 hepatitis C virus: Beware of false-negative RNA detection.
Hepatology. 2010.
PubMed Text format Related articles

PIROTH L , Larsen C, Binquet C, Alric L, et al
Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: The HEPAIG study.
Hepatology. 2010 Sep 7:1916-1923.
PubMed Text format Related articles Abstract available

THOMPSON AJ , Clark PJ, McHutchison JG
Hepatitis C virus nonstructural protein 5A inhibitors: Novel target-Now for new trials and new treatment strategies.
Hepatology. 2010;52:1162-4.
PubMed Text format Related articles

MANGIA A , Andriulli A
Optimal dosage of ribavirin.
Hepatology. 2010;52:1174.
PubMed Text format Related articles

AGHEMO A , Rumi MG, De Nicola S, Colombo M, et al
Twelve-week posttreatment follow-up predicts a sustained virological response to pegylated interferon and ribavirin therapy.
Hepatology. 2010;52:1170-1.
PubMed Text format Related articles

HARRISON SA , Rossaro L, Hu KQ, Patel K, et al
Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy.
Hepatology. 2010;52:864-74.
PubMed Text format Related articles Abstract available

LIAW YF , Sheen IS, Lee CM, Akarca US, et al
Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

August 2010

CHUNG RT , Poordad FF, Hassanein T, Zhou X, et al
Association of host pharmacodynamic effects with virologic response to pegylated interferon alfa-2a/ribavirin in chronic hepatitis C.
Hepatology. 2010 Aug 31:1907-1915.
PubMed Text format Related articles Abstract available

GUPTE AA , Liu JZ, Ren Y, Minze LJ, et al
Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

JONAS MM , Block JM, Haber BA, Karpen SJ, et al
Treatment of children with chronic hepatitis B virus infection in the United States: Patient selection and therapeutic options.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

RAZIORROUH B , Schraut W, Gerlach T, Nowack D, et al
The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function.
Hepatology. 2010 Aug 25:1935-1948.
PubMed Text format Related articles Abstract available

MURATORI L , Muratori P, Lanzoni G, Ferri S, et al
Application of the 2010 American Association for the study of liver diseases criteria of remission to a cohort of Italian patients with autoimmune hepatitis.
Hepatology. 2010.
PubMed Text format Related articles

URBAN TJ , Thompson AJ, Bradrick SS, Fellay J, et al
IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

GOLDEN-MASON L , Cox AL, Randall JA, Cheng L, et al
Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

YEH CT , So M, Ng J, Yang HW, et al
Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

PURNAK T , Efe C, Beyazit Y, Ozaslan E, et al
Serum lipid profile and chronic hepatitis C virus.
Hepatology. 2010.
PubMed Text format Related articles

DE BRUIJNE J , Bergmann JF, Reesink HW, Weegink CJ, et al
Antiviral activity of narlaprevir combined with ritonavir and pegylated interferon in chronic hepatitis C patients.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

YANG X , Haurigot V, Zhou S, Luo G, et al
Inhibition of hepatitis C virus replication using adeno-associated virus vector delivery of an exogenous anti-hepatitis C virus microrna cluster.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

WURSTHORN K , Jung M, Riva A, Goodman ZD, et al
Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

EL CHAAR M , Candotti D, Crowther RA, Allain JP, et al
Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

CHEN EQ , Tang H
The curative efficiency of tenofovir for patients with chronic hepatitis B after failure of nucleoside/nucleotide analogues.
Hepatology. 2010;52:802.
PubMed Text format Related articles

DEBES JD
Hepatitis B in refugees, guessing the prevalence.
Hepatology. 2010;52:802-3.
PubMed Text format Related articles

SALAMONE F , Li Volti G
Targeting heme oxygenase/adiponectin axis for chronic hepatitis C treatment.
Hepatology. 2010;52:801.
PubMed Text format Related articles

RIGAMONTI C , Francesca Donato M, Colombo M
Transient elastography in the early prediction of progressive recurrent hepatitis C following liver transplantation.
Hepatology. 2010;52:800-1.
PubMed Text format Related articles

TUYAMA AC , Hong F, Saiman Y, Wang C, et al
Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: Implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis.
Hepatology. 2010;52:612-22.
PubMed Text format Related articles Abstract available

ASAHINA Y , Tsuchiya K, Tamaki N, Hirayama I, et al
Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection.
Hepatology. 2010;52:518-27.
PubMed Text format Related articles Abstract available

GALLI A , Ceni E, Mello T, Polvani S, et al
Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor gamma-independent regulation of nucleophosmin.
Hepatology. 2010;52:493-505.
PubMed Text format Related articles Abstract available

MACHIDA K , Tsukamoto H, Liu JC, Han YP, et al
c-Jun mediates hepatitis C virus hepatocarcinogenesis through signal transducer and activator of transcription 3 and nitric oxide-dependent impairment of oxidative DNA repair.
Hepatology. 2010;52:480-92.
PubMed Text format Related articles Abstract available

RIJCKBORST V , Hansen BE, Cakaloglu Y, Ferenci P, et al
Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels.
Hepatology. 2010;52:454-61.
PubMed Text format Related articles Abstract available

WOODHOUSE SD , Narayan R, Latham S, Lee S, et al
Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro.
Hepatology. 2010;52:443-53.
PubMed Text format Related articles Abstract available

SU J , Brook RA, Kleinman NL, Corey-Lisle P, et al
The impact of hepatitis C virus infection on work absence, productivity, and healthcare benefit costs.
Hepatology. 2010;52:436-42.
PubMed Text format Related articles Abstract available

LEUTSCHER PD , Lagging M, Buhl MR, Pedersen C, et al
Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C.
Hepatology. 2010;52:430-435.
PubMed Text format Related articles Abstract available

MORIISHI K , Shoji I, Mori Y, Suzuki R, et al
Involvement of PA28gamma in the propagation of hepatitis C virus.
Hepatology. 2010;52:411-20.
PubMed Text format Related articles Abstract available

LOK AS
Drug therapy: tenofovir.
Hepatology. 2010;52:743-7.
PubMed Text format Related articles

July 2010

GREBELY J , Petoumenos K, Hellard M, Matthews GV, et al
Potential role for Interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

PETTA S , Amato M, Cabibi D, Camma C, et al
Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

SCHRAMM C , Weiler-Normann C, Wiegard C, Hellweg S, et al
Treatment response in patients with autoimmune hepatitis.
Hepatology. 2010.
PubMed Text format Related articles

SONNEVELD MJ , Rijckborst V, Boucher CA, Hansen BE, et al
Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

ROOMER R , Hansen BE, Janssen HL, de Knegt RJ, et al
Risk factors for infection during treatment with peginterferon alfa and ribavirin for chronic hepatitis C.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

OZASLAN E
Drug-induced autoimmune hepatitis: An easily reversible type of liver fibrosis?
Hepatology. 2010.
PubMed Text format Related articles

NDONGO N , Berthillon P, Pradat P, Vieux C, et al
Association of anti-E1E2 antibodies with spontaneous recovery or sustained viral response to therapy in patients infected with hepatitis C virus.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

BRENNDORFER ED , Weiland M, Frelin L, Derk E, et al
Anti-tumor necrosis factor alpha treatment promotes apoptosis and prevents liver regeneration in a transgenic mouse model of chronic hepatitis C.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

EFE C , Purnak T, Ozaslan E, Wahlin S, et al
Drug-induced autoimmune hepatitis caused by anti-tumor necrosis factor alpha agents.
Hepatology. 2010.
PubMed Text format Related articles

CREMIEUX P
Methodological issues in a meta-analysis.
Hepatology. 2010;52:395-6.
PubMed Text format Related articles

LANG PA , Recher M, Honke N, Scheu S, et al
Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice.
Hepatology. 2010;52:25-32.
PubMed Text format Related articles Abstract available

LUTGEHETMANN M , Volz T, Kopke A, Broja T, et al
In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice.
Hepatology. 2010;52:16-24.
PubMed Text format Related articles Abstract available

USTUNDAG Y , Topalak O
Think twice if you consider entecavir treatment in cases with lamivudine refractoriness.
Hepatology. 2010;52:397-8.
PubMed Text format Related articles

June 2010

BUTI M , Lurie Y, Zakharova NG, Blokhina NP, et al
Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virologic response.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

POORDAD F , Lawitz E, Shiffman ML, Hassanein T, et al
Virologic response rates of weight-based taribavirin versus ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

THOMPSON AJ , Muir AJ, Sulkowski MS, Patel K, et al
Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype.
Hepatology. 2010.
PubMed Text format Related articles

TOHME RA , Holmberg SD
Is sexual contact a major mode of hepatitis C virus transmission?
Hepatology. 2010.
PubMed Text format Related articles Abstract available

NORTON PA , Menne S, Sinnathamby G, Betesh L, et al
Glucosidase inhibition enhances presentation of de-N-glycosylated hepatitis B virus epitopes by major histocompatibility complex class I in vitro and in woodchucks.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

POCKROS PJ , Hamzeh FM, Martin P, Lentz E, et al
Histologic outcomes in hepatitis C-infected patients with varying degrees of virologic response to interferon-based treatments.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

CHAN HL , Wong VW, Wong GL, Tse CH, et al
A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

FERRI S , Longhi MS, De Molo C, Lalanne C, et al
A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

RAMCHARRAN D , Wahed AS, Conjeevaram HS, Evans RW, et al
Associations between serum lipids and hepatitis C antiviral treatment efficacy.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

CHANG TT , Liaw YF, Wu SS, Schiff E, et al
Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

SHEN L
Vitamin D controls T cell activation: Implication for causal association between vitamin D deficiency and fibrosis in chronic hepatitis C.
Hepatology. 2010.
PubMed Text format Related articles

May 2010

CRUZ AC , Engelson E, Ionescu G, Dubrovskaya V, et al
Hepatitis C treatment in an urban population.
Hepatology. 2010.
PubMed Text format Related articles

HUNG CH , Lee CM, Lu SN, Wang JH, et al
Hepatic steatosis with hepatitis B virus/hepatitis C virus dual infection.
Hepatology. 2010.
PubMed Text format Related articles

March 2010

AKUTA N , Suzuki F, Hirakawa M, Kawamura Y, et al
Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin.
Hepatology. 2010.
PubMed Text format Related articles Abstract available

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.
Design: